BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16150648)

  • 1. Stable transduction of primary human monocytes by simian lentiviral vector PBj.
    Mühlebach MD; Wolfrum N; Schüle S; Tschulena U; Sanzenbacher R; Flory E; Cichutek K; Schweizer M
    Mol Ther; 2005 Dec; 12(6):1206-16. PubMed ID: 16150648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system.
    Schroers R; Sinha I; Segall H; Schmidt-Wolf IG; Rooney CM; Brenner MK; Sutton RE; Chen SY
    Mol Ther; 2000 Feb; 1(2):171-9. PubMed ID: 10933928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
    Schroers R; Davis CM; Wagner HJ; Chen SY
    Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
    Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
    Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap.
    Dardalhon V; Herpers B; Noraz N; Pflumio F; Guetard D; Leveau C; Dubart-Kupperschmitt A; Charneau P; Taylor N
    Gene Ther; 2001 Feb; 8(3):190-8. PubMed ID: 11313790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy.
    Bao L; Guo H; Huang X; Tammana S; Wong M; McIvor RS; Zhou X
    Gene Ther; 2009 Jun; 16(6):788-95. PubMed ID: 19340017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
    Klages N; Zufferey R; Trono D
    Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
    Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
    Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
    Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
    Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
    Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
    Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of targeted gene transfer into human primary T lymphocytes and macrophages using high-titer recombinant HIV vectors.
    Miyake K; Miyake N; Shimada T
    J Biotechnol; 2007 May; 129(3):532-8. PubMed ID: 17307270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
    Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
    J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters.
    Dijon M; Torne-Celer C; Moreau T; Tonnelle C; Chabannon C
    Cytotherapy; 2005; 7(5):417-26. PubMed ID: 16236631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
    Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.